IPRIPR2023-00074Final Written Decision
bluebird bio, Inc. et al.v.Sloan Kettering Institute for Cancer Research et al.
IPR challenge of US 8058061.
Type
IPR
Filed
Oct 18, 2022
Instituted
Apr 24, 2023
Decided
Aug 7, 2025
Patent
Application
12433412
Inventor
Michel Sadelain et al
Granted
Nov 15, 2011
01
Timeline
3 milestones
2022-10-18Petition filed
2023-04-24Institution
2024-04-22Terminated
02
Parties & counsel
Petitioner
bluebird bio, Inc. et al.
Counsel
Modi, Naveenet al
Patent Owner
Sloan Kettering Institute for Cancer Research et al.
Counsel
Glynn, Michaelet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →